- Patients with cancer not only are at increased risk for severe COVID-19, but also face cancer treatment delays and interruptions due to the pandemic, potentially worsening cancer outcomes.
- Nearly 10 million missed cancer screenings in 2020 could lead to diagnoses of advanced-stage cancers and increased cancer deaths in the coming years.
- Early-career investigators, especially women and underrepresented minorities, are uniquely vulnerable to the adverse impacts of the pandemic.
Reno, Nevada (UroToday.com) — The American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care. This first-of-its-kind report provides a comprehensive view of the burden of COVID-19 among patients with cancer; the challenges presented by the pandemic in cancer research and patient care; and the changes implemented during the pandemic that have unexpectedly improved research practices and access to care.